Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome
Abstract T.M. Anoop Background The role of serum free light chain (FLC) as a prognostic biomarker in lymphoproliferative diseases is being increasingly studied. In this study we present the 5-year sur...
Main Authors: | T.M. Anoop, Geetha Narayanan, Steffi Chacko, K.M. Jagathnath Krishna, Sreejith G. Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022-07-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1743426 |
Similar Items
-
Intraoral Non-hodgkin′s Lymphoma In a HIV Patient
by: M Sunitha, et al.
Published: (2006-01-01) -
Epidemiology of Non-Hodgkin’s Lymphoma
by: Krishna C. Thandra, et al.
Published: (2021-01-01) -
Coexistence Between Hodgkin’s Lymphoma and Renal Cell Cancer: Case Report
by: Mustafa Karabıçak, et al.
Published: (2014-11-01) -
IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma
by: Mohammadali Mashhadi, et al.
Published: (2011-09-01) -
IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma
by: Behrooz Najafi, et al.
Published: (2011-10-01)